Zobrazeno 1 - 10
of 186
pro vyhledávání: '"residual platelet reactivity"'
Autor:
M. B. Khakimova, A. L. Komarov, A. B. Dobrovolsky, E. V. Titaeva, V. V. Kadochnikova, D. D. Abramov, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 13, Iss 2, Pp 16-27 (2024)
Introduction. Patients undergoing elective myocardial revascularization require 6 months of dual antiplatelet therapy (DAPT), including aspirin and clopidogrel. In patients with multifocal atherosclerotic lesion (MFA), it may be reasonable to extend
Externí odkaz:
https://doaj.org/article/4032d57357514dc6b0b82b1140824a58
Autor:
Yongkang Zhang, Yuan Zong, Jiarui Liu, Kangli Yin, Yuzhen Wang, Yuefeng Bian, Yichen Huang, Wei Liu, Yemin Cao
Publikováno v:
Cerebrovascular Diseases Extra, Vol 13, Iss 1, Pp 83-89 (2023)
Introduction: There are few studies on the relationship between the occurrence of clopidogrel-related high residual platelet reactivity (HRPR) and estimated glomerular filtration rate (eGFR) at admission in patients with ischemic stroke. The aim of t
Externí odkaz:
https://doaj.org/article/c560a72620714f959c029a6396b45290
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 222-229 (2023)
Aim. Study of the association of polymorphic variants of CYP2C19 (G681A), P2RY12 (H1/H2), ITGB3 (T1565C), ITGA2 (C807T), eNOS3 (T786C) genes with high residual platelet reactivity (HRPR) to clopidogrel and acetylsalicylic acid (ASA) at different term
Externí odkaz:
https://doaj.org/article/abfa8d81f0554ebe8f8ee003fbfd2ff6
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
According to recommendations of ESC 2020-year, de-escalation of therapy with a P2Y12 receptor inhibitor (transition from prasugrel or ticagrelor to clopidogrel) It can be considered as an alternative strategy of dual antiplatelet therapy (DAPT) for p
Externí odkaz:
https://doaj.org/article/8f47e1084fc848af901d29fc6e9dfd01
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I. S. Yavelov
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 72-81 (2020)
In the article, a review is given of the facts that determined contemporary views of the role of clopidogrel in the treatment of acute coronary syndrome. The author described a history of the clinical studies of clopidogrel in acute coronary syndrome
Externí odkaz:
https://doaj.org/article/e77676a377ec42ddb94b0a0de736c15e
Autor:
Zhiyan Liu, Qian Xiang, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Shuqing Chen, Kun Hu, Yanjun Gong, Jie Jiang, Yimin Cui
Publikováno v:
Platelets, Vol 31, Iss 1, Pp 3-14 (2020)
Cigarette smoking is an important cardiovascular risk factor, causing morbidity and mortality. There are many original studies on the impact of smoking, but its influence on platelet ADP-P2Y12 receptor inhibitors lack consistency. Thus, we conducted
Externí odkaz:
https://doaj.org/article/e969815b2c304694b744cd8758293e38
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Thrombosis Journal, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Background Platelet inhibition is important for patients with coronary artery disease. When dual antiplatelet therapy (DAPT) is required, a P2Y12-antagonist is usually recommended in addition to standard aspirin therapy. The most used P2Y12-
Externí odkaz:
https://doaj.org/article/2002f25aa91f4441b077e1fbdb64fa43
Publikováno v:
Thrombosis Journal, Vol 15, Iss 1, Pp 1-8 (2017)
Abstract Background The mechanisms behind residual platelet reactivity (RPR) despite aspirin treatment are not established. It has been shown that coronary artery disease (CAD) patients with high on-aspirin RPR have elevated levels of von Willebrand
Externí odkaz:
https://doaj.org/article/60768e5f95f04de3b73eb0aebaa8dc99